ARID1A and gastric cancer: This result was confirmed using The Cancer Genome Atlas (TCGA [Provisional]) gastric cancer dataset, which showed that PD-L1 mRNA expression was higher in patients with ARID1A truncating mutation (n = 83) than in other patients (n = 286) (P < 0.0001) (Fig. 4d)4.